Ellison says the agreement requires Denmark-based manufacturer Novo Nordisk to cap monthly out-of-pocket payments for insulin at $35 a month for the next five years, even for people without health ...

Novo Nordisk (NVO) has reportedly settled a lawsuit filed by the state of Minnesota over the pricing of its insulin products by agreeing to cap costs at $35 per month. Under the settlement, Novo ...

Novo Nordisk (NVO) stock was down premarket after the company missed on top and bottom lines of second quarter earnings Wednesday. The report comes just a week after the company announced a ...

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.

Then, suddenly, its fortunes took a turn. Novo Nordisk’s share price has plummeted more than 50 percent this year, pushing it out of the top ten list of Europe’s most valuable companies.

Shares in Novo Nordisk NOVO.B 0.16% plunged after it cut its guidance, a result from the company losing its lead in the booming market for weight-loss drugs, opening the door to competitors such ...

Novo Nordisk, which makes blockbuster weight-loss drugs Ozempic and Wegovy, now expects 2025 sales growth at constant exchange rates of 8% to 14%, down from its early May forecast of 13% to 21%.

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its full-year sales and profit outlook for the second time this year. The ...